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Abstract
Kaposi’s sarcoma (KS) is an acquired immunodeficiency syndrome (AIDS)-
related malignancy and may present in the head and neck as an initial 
sign of AIDS. However, it is rare in the nasopharynx. We report a 28-year-
old man who complained of postnasal drip and occasional bloody saliva 
for 2 months. A purple-red bulging nasopharyngeal tumor was found on 
examination; a biopsy specimen proved that it was KS with positive 
human herpes virus type 8 (HHV-8) staining in the tumor cell nuclei. AIDS 
was diagnosed when enzyme immunoassay and Western blot were posi-
tive for serum human immunodeficiency virus. Antiviral therapy was given 
to treat AIDS, and low-dose radiation was given to treat nasopharyngeal 
KS with a complete response. [Tzu Chi Med J 2009;21(4):342–344]
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1. Introduction
Kaposi’s sarcoma (KS) is an angioproliferative malig-
nant neoplasm that arises from mesenchymal pro-
genitor cells infected by human herpes virus-8 (HHV-8) 
and may be multifocal in origin [1,2]. Acquired im-
munodeficiency syndrome (AIDS)-related KS can af-
fect any area of the skin, aerodigestive tract mucous 
membranes, and even the internal organs. The most 
common site reported is the skin on the lower limbs 
[2]. In the head and neck region, the most common 
sites affected are the oral cavity, oropharynx and 
conjunctiva [2–4]. However, the nasopharynx is rarely 
a uniquely affected site of KS. Here, we report KS 
initially presenting as a nasopharyngeal tumor that 
was diagnosed as AIDS-related and which was suc-
cessfully managed with low-dose radiotherapy [4,5]. 
The clinical features and treatment modalities of KS 
are also reviewed.
2. Case report
A 25-year-old man with a history of homosexuality 
came to our outpatient department in April 2005 
complaining of postnasal drip and occasional bloody 
saliva for 2 months. On examination, his local and 
physical condition was grossly normal except for a 
purplish elevated tumor with scattered red plaques in 
the right lateral and posterior walls of the nasophar-
ynx (Fig. 1), and many small lymph nodes palpated 
at the periauricular and bilateral neck areas (Fig. 2). 
A punch biopsy was done immediately through the 
nose. Pathological examination showed KS (Fig. 3) 
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with positive HHV-8 staining in the tumor cell nuclei 
(Fig. 4). Positive results for serum human immuno-
deficiency virus (HIV) were revealed on enzyme im-
munoassay and Western blot. Thereafter, computed 
tomography scan of the head and neck showed an 
elevated contrast-enhanced mass in the posterior 
wall of the nasopharynx with multiple small lymph 
nodes at the left periauricular, bilateral periparotid 
and bilateral neck areas, which were compatible with 
KS and AIDS-related lymphadenopathy (Fig. 2).
The patient was referred to the Department of 
Infectious Diseases, where antiviral treatment and 
local radiotherapy were given. Complete response and 
local symptom relief were noted after radiotherapy 
with 28 Gy (2 Gy/fraction, 5 times/week). Subsequently, 
KS was also noted on his chest wall and skin of the 
scrotum. CO2 laser treatment was administered for 
the former and local radiation for the latter. The pa-
tient received highly active antiretroviral therapy 
(HAART) and remained in stable condition as of July 
2008.
3. Discussion
KS was first described by Moritz Kaposi, a Hungarian 
dermatologist practicing at the University of Vienna 
in 1872. The incidence of KS is 310 times higher 
Fig. 1 — Nasopharyngeal fiberscopy reveals a purplish 
elevated mass in the right lateral and posterior walls of 
the nasopharynx with scattered red plaques (arrows).
Fig. 2 — Computed tomography shows a contrast-
enhanced mass in the right lateral and posterior walls of 
the nasopharynx (short arrow); left periauricular lymphad-
enopathy is also noted (long arrow).
Fig. 3 — Kaposi’s sarcoma composed of spindle cells (long 
arrow) with slit spaces filled with erythrocytes (short arrow) 
in the submucosa of the nasopharynx (hematoxylin & eosin, 
400´).
Fig. 4 — Immunohistochemical stain shows human herpes 
virus-8 in the tumor cell nuclei (arrow) which are stained 
brown (latent nuclear antigen-1, 400´).
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among AIDS patients than in the general population 
[1]. The first case of epidemic or AIDS-associated KS 
was reported in 1981 [2]. It is more aggressive in 
patients with AIDS. KS is now the malignant neoplasm 
that is most frequently associated with AIDS—it has 
been seen in up to 80% of AIDS patients in some 
series, and is more prevalent in male homosexuals 
than in other HIV risk groups [1,2].
In 1993, Riderer et al reported that 163 (70%) of 
the 233 HIV-positive patients diagnosed or treated in 
their otolaryngological department had AIDS [3]. Of 
these, 46 (28%) had KS in the head and neck region. 
KS was most often located in the mouth (32/46, 67%), 
oropharynx (30/46, 65%) and skin (18/46, 39%), 
while the larynx (5/46, 10.9%), hypopharynx (4/46, 
8.7%), lymph nodes (3/46, 6.5%) and nasopharynx 
(2/46, 4.3%) were rarely involved. In 40 of the 46 KS 
patients (87%), more than one anatomical site of the 
head and neck was involved. In 15 of the 233 HIV-
infected patients (6.4%), KS of the head and neck 
region was the initial symptom of HIV infection. 
Unifocal KS in the nasopharynx is very rare and KS 
in the head and neck area as an initial symptom of 
HIV-infected patients is also rare [3].
Clinically, KS must be differentiated from other na-
sopharyngeal angiogenic tumors such as angiofibroma. 
The latter is a lobulated, firm, nonencapsulated, 
pink-gray mass arising from the fibrovascular stroma 
in the posterolateral wall of the roof of the nose; a 
punch biopsy is not done for this tumor because of 
the possibility of massive bleeding. In contrast, KS 
presents grossly as small well-delineated plaque le-
sions or larger infiltrative nodules arising from the 
posterolateral wall of the nasopharynx; a punch bi-
opsy can be done for mucosal and skin KS for de-
finitive diagnosis without causing intensive bleeding. 
Still, if any hypervascular tumor is suspected, an en-
doscopy-guided biopsy should be done in the oper-
ating room to see the tumor clearly, with facilities 
well-prepared to control possible bleeding [3].
KS is not considered curable with standard thera-
pies, and treatment decisions are instead guided by 
the presence and extent of symptomatic or extr   acu-
taneous KS [6]. It is now accepted that most, if not 
all, patients with KS should be treated with antiretro-
viral drugs such as the HAART regimen. The benefits 
of HAART include inhibition of HIV replication, dimin-
ished production of Tat protein, amelioration of the 
host’s immune response to HHV-8, and direct antian-
giogenic activity by some protease inhibitors. HAART 
taken together with systemic chemotherapy such as 
liposomal doxorubicin, daunorubicin, or paclitaxel 
may be used to treat advanced or progressive dis-
ease [6,7].
Local therapy is most useful for localized KS lesions 
for local symptomatic control and/or cosmesis, but 
will not prevent the development of new lesions at 
untreated sites. Alitretinoin gel 0.1% is the only topical 
patient-administered therapy approved for the treat-
ment of KS, but it is only suitable for skin KS [6,7]. 
Alternative local treatments include intralesional chem-
otherapy using vinblastine, radiation therapy, laser 
therapy, and cryotherapy. Low-dose radiation therapy 
can be employed to palliate symptoms [5]. Complete 
response to radiation therapy is found in 50–80% of 
patients. Antiangiogenesis therapy is a new modality 
that is currently being developed [6,7].
In summary, AIDS-related KS varies from minimal 
to fulminant and from unifocal to multifocal disease. 
Head and neck presentations and diseases in HIV-
infected patients are new challenges for otolaryngolo-
gists in the diagnosis and treatment of these conditions 
[3,6,7].
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